Effect of increased 99mTc/99Tc ratios on count rates in sentinel node procedures: A randomised study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 9, 2003, Pages 1231-1235

  Gommans, G M M ^a   Van der Zant, F M ^b   Van der Schors, T G ^b   Van Dongen, A ^b   Teule, G J J ^b   Clarijs, W W J ^b   Langenhorst, B L A M ^b   De Waard, J W D ^a  

^a WFG Hospital Hoorn   (Netherlands)

^b Westfries Hospital Hoorn ^*

Author keywords

Breast cancer; Colloid; Sentinel node

Indexed keywords

ALBUMIN TC 99M COLLOID; NANOCOLL TC 99M; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BREAST AREOLA; BREAST BIOPSY; BREAST CANCER; CANCER SCINTISCANNING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELUTION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; ISOTOPE LABELING; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENTINEL LYMPH NODE; VACUUM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOMETRY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0141447471     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1227-9     Document Type: Article

References (26)

1. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
2. Krag DN, Weaver DL, Alex JC, Fairbank JC. Surgical resection and radiolocalisation of the sentinel node in breast cancer using a gammaprobe. Surg Oncol 1993; 2:335-339.
3. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186:275-283.
4. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RPA, van Diest PJ, Teule GJJ. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38:366-368.
5. Haigh PI, Hansen NM, Guilliano AE, Edwards GK, Ye W, Glass EC. Factors affecting sentinel node localisation during preoperative breast lymphoscintigraphy. J Nucl Med 2000; 41:1682-1688.
6. Kaufman CS, Jacobson-Kaufman L, Thorndike-Christ T, Kaufman L, Tabar L. A treatment scale for axillary management in breast cancer. Am J Surg 2001; 182:377-383.
7. Van de Ent FWC, Kengen RAM, van der Poll HAG, Hoofdwijk AGM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10-mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999; 25:24-29.
8. Bostick PJ, Giuliano AE. Vital dues in sentinel node localisation. Semin Nucl Med 2000; 1:18-24.
9. Kaplan WD, Davies MA, Rose CHN. A comparison of two technetium-99m labelled radiopharmaceuticals for lymphoscintigraphy: concise communication. J Nucl Med 1979; 20: 933-937.
10. Valdés Olmos RA, Hoefnagel CA, Nieweg OE, Jansen L, Rutgers EJT, Borger J, Horenblas S, Kroon BBR. Lymphoscintigraphy in oncology: a rediscovered challenge Eur J Nucl Med 1999; 226 (Suppl):S2-S10.
11. Imoto S, Murakami K, Ikeda H, Fukukita H, Moriyama N. Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer. Ann Nucl Med 1999; 13:325-329.
12. Edreira MM, Colombo LL, Perez JH, Sajaroff EO, Castiglia SG. In vivo evaluation of three different 99m-Tc labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun 2001; 22:499-504.
13. Hodgson N, Zabel P, Mattar AG, Engel CJ, Girvan D, Holliday R. A new radiopharmaceutical for sentinel node detection in breast cancer. Ann Surg Oncol 2001; 8:1333-1337.
14. Mariani G, Moresco L, Viaale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001; 42:1198-1215.
15. Tanis PJ, van Sandick JW, Nieweg OE, Valdes Olmos RA, Rutgers EJT, Hoefnagel CA, Kroon BBR. The hidden sentinel node in breast cancer. Eur J Nucl Med 2002; 29:305-311.
16. Moffat FI, Gules SA, Sittler SY, et al. Unfiltered sulphur colloid and sentinel node biopsy for breast cancer: technical and kinetic considerations. Ann Surg Oncol 1999; 6:746-755.
17. 99mtechnetium sulfur colloid. Am Coll Surg Surg 2000; 191:479-489.
18. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multi center validation study. N Eng J Med 1998; 339:941-946.
19. Wong SI, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer; impact of the number of sentinel nodes removed of the false negative rate. J Am Coll Surg 2001; 192:684-691.
20. Bergkvist L, Frisell J, Lijegren G, Celebiolglu F, Damm S, Thorns M. Multi center study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001; 88:1644-1648.
21. Meijer S, Torrenga H, van der Sijp JRM. Negative sentinel nodes in breast cancer patients: good indicator for continued absence of axillary metastasis. Ned Tijdschr Geneesk 2002; 146:942-947.
22. Valdes Olmos RA, Tanis PJ, Hoefnagel CA, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22:579-586.
23. Gommans GMM, Boer RO, van Dongen A, et al. Further optimising of technetium-99m-Nanocoll sentinel node localisation in carcinoma of the breast by improved labeling. Eur J Nucl Med 2001; 28:1450-1455.
24. Krynyckyi BR, Zhang ZY. Kim CK, Lipszyc H, Mosci K, Machac J. Effect of high specific activity sulphur colloid preparations on sentinel node count rates. Clin Nucl Med 2001; 27:92-95.
25. Nycomed Amersham Sorin S.r.I. Package Insert Nanocoll. SPC October 1999.
26. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000; 1:25-32.